Literature DB >> 22682369

Detecting psychotic symptoms in Indigenous populations: a review of available assessment tools.

Célia Demarchi1, India Bohanna, Bernhard T Baune, Alan R Clough.   

Abstract

As efforts to shorten the duration of untreated psychosis increase, there is a need for short screening instruments to identify those at-risk. It is feared that remote Indigenous populations, manifesting many of the risk factors associated with schizophrenia and often lacking access to adequate mental health services, may be overlooked as the general population effort shifts towards early detection. This article aimed to review studies investigating psychotic symptoms in Indigenous communities in Australia, New Zealand, Canada and United States of America and aimed to evaluate the usefulness of the instruments. Eleven relevant studies were identified using seven unique instruments. The available instruments assessed psychotic symptoms to varying degrees, although no screener for early detection was found thus supporting concerns that these disadvantaged populations do not have access to suitable support enabling early detection of psychosis. We recommend that a rapid screening tool for detecting at-risk individuals be developed and validated for community use in Indigenous populations living in remote areas.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22682369     DOI: 10.1016/j.schres.2012.05.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  2 in total

1.  A Culturally-Grounded Biopsychosocial Assessment Utilizing Indigenous Ways of Knowing with the Cowichan Tribes.

Authors:  Emma Elliott-Groves
Journal:  J Ethn Cult Divers Soc Work       Date:  2019-02-06

2.  Measurement properties of the Health of the Nation Outcome Scales (HoNOS) family of measures: protocol for a systematic review.

Authors:  Meredith G Harris; Claudia Sparti; Roman Scheurer; Tim Coombs; Jane Pirkis; Torleif Ruud; Steve Kisely; Ketil Hanssen-Bauer; Johan Siqveland; Philip M Burgess
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.